News Sentiment

ARVN sentiment intelligence

Arvinas Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 51 Balanced news tone 62 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 8.27 Week of 10 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

78/100 classification confidence.

Company focus 53

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

-1.4% over one week, +9.1% over four weeks, trend inactive, and below fair value.

Latest direct headline Negative

Trading the Move, Not the Narrative: (ARVN) Edition

Market Reaction

Balanced read

58/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 78/100 classification
One-week reaction -1.4% Price digesting
Trend fit Trend inactive 9.1% over four weeks
Fair value -57.9% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 9
Neutral 48
Negative 5

Relevance

Why the article matched

Direct first
Direct company coverage 53
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 19
Market source 10
simplywall.st 5
TradingView 3
TradingKey 3
Investing.com 3
GlobeNewswire 3
Investing.com Nigeria 2

Event Lens

What the news is about

Classified themes
Market update 31
Earnings 17
Deals and strategy 5
Analyst action 4
Regulatory and legal 2
Capital return 1
Guidance 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 62
Stock Titan Direct company coverage

Arvinas (NASDAQ: ARVN) insider sells 2,642 shares; May sale of 9,657 noted

An insider at Arvinas (NASDAQ: ARVN) sold 2,642 shares on June 17, 2026, stemming from vested restricted stock units. This Form 144 SEC filing also notes a previous sale of 9,657 common shares by Angela Cacace on May 11, 2026, for $95,965.47. The transactions are considered routi

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 13:10
Source
Stock Titan
Bitget Direct company coverage

According to a document submitted to the U.S. Securities and Exchange Commission, an agreement between Arvinas Holding Company LLC and Pfizer indicates that both parties are eligible for milestone payments totaling up to 320 millions USD, along with a

An agreement between Arvinas Holding Company LLC and Pfizer, detailed in a U.S. SEC document, outlines potential milestone payments of up to $320 million and a tiered royalty structure for both companies. These payments are phased based on R&D progress, regulatory approvals, and

Tone
Positive 71/100
Event
Regulatory and legal
Published
16 Jun 2026 21:40
Source
Bitget